Literature DB >> 16625459

[Socioeconomic characteristics, quality of life, and state of knowledge of patients with hepatitis C viral infection in Germany--socioeconomic aspects in hepatitis C].

C Niederau1, G Bemba, A Kautz.   

Abstract

BACKGROUND: Little is known as yet about the socio-economic consequences for patients with hepatitis C in Germany. AIMS AND METHODS: The study of the Deutsche Leberhilfe e. V., supported by the federal hepatitis competence net, prospectively analyzed questionnaires about quality-of-life, education and work situation, insurance, and various other socio-economical aspects of patients with chronic hepatitis C. The questionnaire included questions about the information status of patients concerning hepatitis C in general and their individual disease. Overall, 1500 questionnaires were distributed by clinics, general practitioners, patient-support groups and via the internet; 714 were sent back and analyzed.
RESULTS: Most of the 714 patients were born in Germany; 56 % were women and 44 % men, with a mean age of 52 years and a hepatitis duration of 18 years. More than 60 % of subjects younger than 65 years of age did not have a regular job, and 27 % were already retired. Only 47 % had a sufficient retirement insurance, whereas almost all had a health insurance. Only 12 % had an insurance covering work invalidity, and of those who had applied for the latter insurance, it was denied in 29 %. About 80 % of subjects reported that the hepatitis disturbed various aspects of their life. Only 4 % considered the public knowledge about hepatitis C as good or very good, but 80 % as bad or very bad. Of the subjects 40 % did not know how they had been infected; 37 % considered blood products as their infection mode, but only 10 % drug abuse. Almost all subjects knew that HCV cannot be transmitted via shaking hands, use of bathrooms, kisses or food (< 1 %, respectively). Surgery (17 %) and the dentist (15 %), however, were mentioned relatively often as a major risk for infection. About 80 % of subjects knew recent quantitative data on ALT and HCV-RNA, their genotype and the results of liver biopsy. Both mental and physical scores in the SF12 questionnaire were markedly reduced by about one standard deviation in subjects with HCV infection when compared with the general German population. Mental and physical scores deteriorated with increases in inflammatory and fibrosis scores. Subjects with negative HCV-RNA and normal ALT had the best quality of life, whereas subjects with high levels of HCV-RNA and ALT had the worst.
CONCLUSIONS: The data show that the public opinion is wrong when pretending that hepatitis C today is just a disease of drug addicts. Our analysis demonstrates for the first time that many HCV-infected subjects in Germany have problems with their insurance and jobs. German subjects are well informed about their infection including genotype, liver histology, ALT and HCV-RNA; on the other hand, there are information deficits and fears concerning the mode of infection. The recent analysis clearly shows that HCV-infected subjects consider the public information about the HCV infection as catastrophically bad. The recent data in addition show that elimination of HCV decisively ameliorates quality of life, whereas mental and physical health get increasingly worse with progressive liver disease and unsuccessful antiviral therapies.

Entities:  

Mesh:

Year:  2006        PMID: 16625459     DOI: 10.1055/s-2006-926510

Source DB:  PubMed          Journal:  Z Gastroenterol        ISSN: 0044-2771            Impact factor:   2.000


  5 in total

1.  Chronic hepatitis C: treat or wait? Medical decision making in clinical practice.

Authors:  Claus Niederau; Dietrich Hüppe; Elmar Zehnter; Bernd Möller; Renate Heyne; Stefan Christensen; Rainer Pfaff; Arno Theilmeier; Ulrich Alshuth; Stefan Mauss
Journal:  World J Gastroenterol       Date:  2012-03-28       Impact factor: 5.742

Review 2.  Hepatitis C virus-associated neurocognitive and neuropsychiatric disorders: Advances in 2015.

Authors:  Salvatore Monaco; Sara Mariotto; Sergio Ferrari; Massimiliano Calabrese; Gianluigi Zanusso; Alberto Gajofatto; Domenico Sansonno; Franco Dammacco
Journal:  World J Gastroenterol       Date:  2015-11-14       Impact factor: 5.742

Review 3.  Hepatitis C virus infection and the brain.

Authors:  Karin Weissenborn; Anita B Tryc; Meike Heeren; Hans Worthmann; Henning Pflugrad; Georg Berding; Martin Bokemeyer; Hans L Tillmann; Annemarie Goldbecker
Journal:  Metab Brain Dis       Date:  2009-01-07       Impact factor: 3.584

4.  Long-term effects of treatment and response in patients with chronic hepatitis C on quality of life. An international, multicenter, randomized, controlled study.

Authors:  Geert Bezemer; Arthur R Van Gool; Elke Verheij-Hart; Bettina E Hansen; Yoav Lurie; Juan I Esteban; Martin Lagging; Francesco Negro; Stefan Zeuzem; Carlo Ferrari; Jean-Michel Pawlotsky; Avidan U Neumann; Solko W Schalm; Robert J de Knegt
Journal:  BMC Gastroenterol       Date:  2012-01-31       Impact factor: 3.067

5.  The effect of education on quality of life in patients under interferon therapy.

Authors:  Ahmad Ali Asadi Noghabi; Mitra Zandi; Abbas Mehran; Seyed Moayed Alavian; Ali Hasanpour Dehkordi
Journal:  Hepat Mon       Date:  2010-09-01       Impact factor: 0.660

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.